Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harrow (HROW) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Harrow (HROW) over the last 13 years, with Q1 2025 value amounting to $38000.0.

  • Harrow's Gains from Investment Securities fell 8992.04% to $38000.0 in Q1 2025 from the same period last year, while for Sep 2025 it was $38000.0, marking a year-over-year decrease of 9882.35%. This contributed to the annual value of $327831.0 for FY2024, which is 15577.03% up from last year.
  • According to the latest figures from Q1 2025, Harrow's Gains from Investment Securities is $38000.0, which was down 8992.04% from $2.9 million recorded in Q3 2024.
  • In the past 5 years, Harrow's Gains from Investment Securities ranged from a high of $2.9 million in Q1 2023 and a low of -$1.7 million during Q4 2021
  • Moreover, its 5-year median value for Gains from Investment Securities was $252587.0 (2023), whereas its average is $716254.0.
  • In the last 5 years, Harrow's Gains from Investment Securities skyrocketed by 23350000.0% in 2021 and then crashed by 9527.57% in 2023.
  • Over the past 5 years, Harrow's Gains from Investment Securities (Quarter) stood at -$1.7 million in 2021, then skyrocketed by 166.13% to $1.2 million in 2022, then crashed by 88.87% to $128174.0 in 2023, then surged by 2125.88% to $2.9 million in 2024, then tumbled by 98.67% to $38000.0 in 2025.
  • Its Gains from Investment Securities stands at $38000.0 for Q1 2025, versus $2.9 million for Q3 2024 and $377000.0 for Q1 2024.